UMIN ID: C000000025
Registered date:31/12/2006
Docetaxel/5'DFUR or Docetaxel for advanced or recurrent gastric cancer as 2nd line chemotherapy
Basic Information
| Recruitment status | |
|---|---|
| Health condition(s) or Problem(s) studied | gastric cancer |
| Date of first enrollment | 2004/01/01 |
| Target sample size | 110 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Docetaxel 60 mg/m2 iv (tri-weekly) and 5'DFUR 600 mg/body orally (daily), as one course. This is continued until PD or unacceptable toxicity occurs or patients choose to discontinue the treatment. Docetaxel 60 mg/m2 iv (tri-weekly), as one course. This is continued until PD or unacceptable toxicity occurs or patients choose to discontinue the treatment. |
Outcome(s)
| Primary Outcome | response rate, survival, toxicity |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1. serious complications 2. infection 3. peripheral neuropathy 4. other cancers (except cured cancer) 5. brain metastasis 6. severe pleural effusion or severe ascites 7. allergy to polysorbate 80 8. drug allergy 9. pregnant or lactational |
Related Information
| Primary Sponsor | Shinshu Gastroenterological Cancer Study Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | none |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Fukuto Maruta |
| Address | Asahi 3-1-1, Matsumoto, Nagano, 390-8621, Japan Japan |
| Telephone | 0263-37-2654 |
| Affiliation | Shinshu University School of Medicine Gastroenterological Surgery |
| scientific contact | |
| Name | Fukuto Maruta |
| Address | Asahi 3-1-1, Matsumoto, Nagano, 390-8621, Japan Japan |
| Telephone | 0263-37-2654 |
| Affiliation | Shinshu University School of Medicine Department of Gastroenterological Surgery |